Fusion's First Movers
Google's landmark power purchase deal with Commonwealth Fusion Systems signals that commercially viable fusion energy is becoming reality. This collection features carefully selected companies positioned to benefit as corporate adoption accelerates this revolutionary clean energy source.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
ALTC ACQUISITION CORP-CL A
OKLO
Current price
$65.41
A developer of advanced fission power plants that will benefit from the increased investment and positive regulatory outlook for all next-generation n...
A developer of advanced fission power plants that will benefit from the increased investment and positive regulatory outlook for all next-generation nuclear technologies.
Centrus Energy Corp
LEU
Current price
$168.84
As a supplier of nuclear fuel components and technical solutions, this company benefits from the positive momentum for the entire nuclear energy ecosy...
As a supplier of nuclear fuel components and technical solutions, this company benefits from the positive momentum for the entire nuclear energy ecosystem.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Google's fusion energy purchase agreement marks a turning point, moving fusion from research labs into commercial reality. This creates a massive opportunity for companies that will build and support the infrastructure needed for this revolutionary clean energy source. We've identified the key players positioned for long-term growth.
What You Need to Know
This theme represents a long-term growth opportunity as the fusion energy ecosystem develops over the coming decades. The companies span multiple sectors including advanced nuclear technology, materials suppliers, grid modernization, and utilities that could adopt fusion power.
Why These Stocks
We've selected companies across the entire value chain required to make fusion energy commercially viable. From nuclear tech developers to uranium suppliers, from grid infrastructure providers to potential fusion power customers, these carefully chosen stocks give you diverse exposure to this emerging opportunity.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+5.27%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 5.27% over the next year.
Stocks Rated Buy by Analysts
13 of 14 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
Energy's Next Big Thing
Google's power purchase deal with Commonwealth Fusion Systems isn't just news—it's validation that fusion energy is becoming commercially viable. These companies are at the beginning of what could be a multi-decade growth story.
Getting In Early
Many investors don't yet realize the massive infrastructure build-out that fusion energy will require. This carefully selected group gives you access to companies positioned to benefit from the billions in capital that will flow into this sector.
Not Just Clean—Revolutionary
Fusion energy could transform our world with abundant, zero-carbon electricity. As corporate customers like Google drive commercial adoption, these suppliers and infrastructure companies stand to benefit first and most dramatically.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.